Acrivon Therapeutics, Inc. (ACRV) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$84.11M | +5.7% |
| 2024 | -$89.20M | -32.9% |
| 2023 | -$67.10M | -105.5% |
| 2022 | -$32.66M | -101.8% |
| 2021 | -$16.18M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$84.11M | +5.7% |
| 2024 | -$89.20M | -32.9% |
| 2023 | -$67.10M | -105.5% |
| 2022 | -$32.66M | -101.8% |
| 2021 | -$16.18M | — |